![Mark R. Willig](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Mark R. Willig
Directeur Général chez Key Proteo Inc
Postes actifs de Mark R. Willig
Sociétés | Poste | Début | Fin |
---|---|---|---|
Key Proteo Inc
![]() Key Proteo Inc Medical/Nursing ServicesHealth Services Key Proteo Inc specializes in novel peptide screening for newborn babies and is specialized in multiplex analysis for extremely low abundance proteins from a few drops of blood (DBS). The company is located in the US. The American company's mission is to provide preemptive treatment for genetic diseases before they are clinically manifested by expanding and improving newborn screening programs. | Directeur Général | - | - |
President | - | - |
Historique de carrière de Mark R. Willig
Anciens postes connus de Mark R. Willig
Sociétés | Poste | Début | Fin |
---|---|---|---|
Exiqon, Inc. | Corporate Officer/Principal | 01/11/2009 | - |
Specialty Laboratories, Inc.
![]() Specialty Laboratories, Inc. Medical/Nursing ServicesHealth Services Specialty Laboratories, Inc. provides clinical reference laboratory services. It focuses on cutting-edge research and development of existing diagnostic tests to produce assays. The company was founded in 1975 and is located in Valencia, CA. | Sales & Marketing | - | 01/06/2005 |
ROSETTA GENOMICS LTD. | Corporate Officer/Principal | 20/10/2016 | - |
Agendia, Inc.
![]() Agendia, Inc. Pharmaceuticals: MajorHealth Technology Agendia, Inc. operates as a molecular diagnostics company. It develops and markets FFPE-based genomic diagnostic products, which help support physicians with their treatment decisions. Agendia?s tests can help physicians assess a patient?s individual risk for metastasis, it benefits from chemo, hormonal or combination therapy. The company was founded by Laura van't Veer and Ren? Bernards in 2003 and is headquartered in Irvine, CA. | Sales & Marketing | - | - |
Abbott Diagnostics, Inc.
![]() Abbott Diagnostics, Inc. Medical SpecialtiesHealth Technology Abbott Diagnostics, Inc. develops, manufactures and sells medical diagnostic instrument, test and automation products. The company is headquartered in Santa Clara, CA. | Corporate Officer/Principal | - | - |
Myriad Genetic Laboratories, Inc.
![]() Myriad Genetic Laboratories, Inc. Miscellaneous Commercial ServicesCommercial Services Myriad Genetic Laboratories, Inc. provides cancer predisposition testing services. It operates as a biopharmaceutical company that focuses on developing therapeutic and predictive medicine products. The company was founded on October 11, 1995 and is headquartered in Salt Lake City, UT. | Sales & Marketing | - | - |
THERMO FISHER SCIENTIFIC | Sales & Marketing | - | - |
CARDIODX INC | Sales & Marketing | 01/01/2013 | - |
Formation de Mark R. Willig
University of Missouri | Undergraduate Degree |
Statistiques
Internationale
Etats-Unis | 10 |
Israël | 2 |
Opérationnelle
Sales & Marketing | 5 |
Corporate Officer/Principal | 3 |
Undergraduate Degree | 1 |
Sectorielle
Health Technology | 5 |
Health Services | 4 |
Consumer Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Sociétés cotées | 2 |
---|---|
THERMO FISHER SCIENTIFIC | Health Technology |
ROSETTA GENOMICS LTD. | Health Technology |
Entreprise privées | 7 |
---|---|
Specialty Laboratories, Inc.
![]() Specialty Laboratories, Inc. Medical/Nursing ServicesHealth Services Specialty Laboratories, Inc. provides clinical reference laboratory services. It focuses on cutting-edge research and development of existing diagnostic tests to produce assays. The company was founded in 1975 and is located in Valencia, CA. | Health Services |
CardioDx, Inc.
![]() CardioDx, Inc. Medical/Nursing ServicesHealth Services CardioDx, Inc. operates as a cardiovascular genomic diagnostics firm. It develops proprietary tests that improve treatment decisions and patient outcomes on coronary artery disease, cardiac arrhythmia, and heart failure. The company was founded by David L. Levison and Christopher R. Burrow in 2004 and is headquartered in Redwood, CA. | Health Services |
Myriad Genetic Laboratories, Inc.
![]() Myriad Genetic Laboratories, Inc. Miscellaneous Commercial ServicesCommercial Services Myriad Genetic Laboratories, Inc. provides cancer predisposition testing services. It operates as a biopharmaceutical company that focuses on developing therapeutic and predictive medicine products. The company was founded on October 11, 1995 and is headquartered in Salt Lake City, UT. | Commercial Services |
Abbott Diagnostics, Inc.
![]() Abbott Diagnostics, Inc. Medical SpecialtiesHealth Technology Abbott Diagnostics, Inc. develops, manufactures and sells medical diagnostic instrument, test and automation products. The company is headquartered in Santa Clara, CA. | Health Technology |
Agendia, Inc.
![]() Agendia, Inc. Pharmaceuticals: MajorHealth Technology Agendia, Inc. operates as a molecular diagnostics company. It develops and markets FFPE-based genomic diagnostic products, which help support physicians with their treatment decisions. Agendia?s tests can help physicians assess a patient?s individual risk for metastasis, it benefits from chemo, hormonal or combination therapy. The company was founded by Laura van't Veer and Ren? Bernards in 2003 and is headquartered in Irvine, CA. | Health Technology |
Exiqon, Inc. | |
Key Proteo Inc
![]() Key Proteo Inc Medical/Nursing ServicesHealth Services Key Proteo Inc specializes in novel peptide screening for newborn babies and is specialized in multiplex analysis for extremely low abundance proteins from a few drops of blood (DBS). The company is located in the US. The American company's mission is to provide preemptive treatment for genetic diseases before they are clinically manifested by expanding and improving newborn screening programs. | Health Services |
- Bourse
- Insiders
- Mark R. Willig
- Expérience